RAPP - Company ID 0002012593
Rapport Therapeutics, Inc. has filed 195 public company documents between 2024 and 2026. The most frequent type is insider trade (71 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| 3 | New insider ownership | 2y ago2024-06-06 | 2024-06-06 | View filing |
| 8-A12B | 8-A12B | 2y ago2024-06-04 | - | View filing |
| CORRESP | Company correspondence | 2y ago2024-06-04 | - | View filing |
| CORRESP | Company correspondence | 2y ago2024-06-04 | - | View filing |
| CORRESP | Company correspondence | 2y ago2024-06-03 | - | View filing |
| S-1/A | S-1/A | 2y ago2024-06-03 | - | View filing |
| CORRESP | Company correspondence | 2y ago2024-05-29 | - | View filing |
| UPLOAD | SEC correspondence | 2y ago2024-05-24 | - | View filing |
| CORRESP | Company correspondence | 2y ago2024-05-17 | - | View filing |
| S-1 | IPO registration | 2y ago2024-05-17 | - | View filing |
| UPLOAD | SEC correspondence | 2y ago2024-05-13 | - | View filing |
| SEC STAFF LETTER | SEC STAFF LETTER | 2y ago2024-05-03 | - | View filing |
| DRSLTR | DRSLTR | 2y ago2024-04-29 | - | View filing |
| DRS/A | DRS/A | 2y ago2024-04-29 | - | View filing |
| UPLOAD | SEC correspondence | 2y ago2024-04-24 | - | View filing |
| DRS | DRS | 2y ago2024-03-27 | - | View filing |